{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:55:25Z","timestamp":1778878525832,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21NS103009"],"award-info":[{"award-number":["R21NS103009"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01NS103883"],"award-info":[{"award-number":["U01NS103883"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1RC4NS073009"],"award-info":[{"award-number":["1RC4NS073009"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS097903"],"award-info":[{"award-number":["R01NS097903"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R35NS127253"],"award-info":[{"award-number":["R35NS127253"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R37NS033123"],"award-info":[{"award-number":["R37NS033123"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jbc.2022.102228","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T20:54:34Z","timestamp":1656708874000},"page":"102228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["A quantitative high-throughput screen identifies compounds that lower expression of the SCA2-and ALS-associated gene ATXN2"],"prefix":"10.1016","volume":"298","author":[{"given":"Daniel R.","family":"Scoles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandi","family":"Gandelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharan","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Dexheimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warunee","family":"Dansithong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karla P.","family":"Figueroa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lance T.","family":"Pflieger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Redlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen C.","family":"Kales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongmao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Damoiseaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Simeonov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajit","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan M.","family":"Pulst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2022.102228_bib1","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0014-4886(03)00287-5","article-title":"Identification and expression of the gene for human ataxin-2-related protein on chromosome 16","volume":"184","author":"Figueroa","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jbc.2022.102228_bib2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1212\/WNL.55.4.569","article-title":"Late-onset SCA2: 33 CAG repeats are sufficient to cause disease","volume":"55","author":"Fernandez","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jbc.2022.102228_bib3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng1196-269","article-title":"Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2","volume":"14","author":"Pulst","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbc.2022.102228_bib4","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature09320","article-title":"Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS","volume":"466","author":"Elden","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2022.102228_bib5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nature22038","article-title":"Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice","volume":"544","author":"Becker","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2022.102228_bib6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ng1196-285","article-title":"Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG\/glutamine repeats","volume":"14","author":"Imbert","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbc.2022.102228_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/ng1196-277","article-title":"Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT","volume":"14","author":"Sanpei","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbc.2022.102228_bib8","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1091\/mbc.e06-12-1120","article-title":"Ataxin-2 interacts with the DEAD\/H-box RNA helicase DDX6 and interferes with P-bodies and stress granules","volume":"18","author":"Nonhoff","year":"2007","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jbc.2022.102228_bib9","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/hmg\/9.9.1303","article-title":"A\u00a0novel protein with RNA-binding motifs interacts with ataxin-2","volume":"9","author":"Shibata","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2022.102228_bib10","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1073\/pnas.071024998","article-title":"Structure and function of the C-terminal PABC domain of human poly(A)-binding protein","volume":"98","author":"Kozlov","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2022.102228_bib11","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/hmg\/dds479","article-title":"Ataxin-2 interacts with FUS and intermediate-length polyglutamine expansions enhance FUS-related pathology in amyotrophic lateral sclerosis","volume":"22","author":"Farg","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2022.102228_bib12","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1038\/s41467-018-06041-3","article-title":"Staufen1 links RNA stress granules and autophagy in a model of neurodegeneration","volume":"9","author":"Paul","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2022.102228_bib13","article-title":"Staufen blocks autophagy in neurodegeneration","author":"Paul","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.jbc.2022.102228_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005182","article-title":"Ataxin-2 regulates RGS8 translation in a new BAC-SCA2 transgenic mouse model","volume":"11","author":"Dansithong","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jbc.2022.102228_bib15","doi-asserted-by":"crossref","first-page":"9148","DOI":"10.1523\/JNEUROSCI.0660-09.2009","article-title":"Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2","volume":"29","author":"Liu","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jbc.2022.102228_bib16","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1523\/JNEUROSCI.18-03-00905.1998","article-title":"RGS4 inhibits signaling by group I metabotropic glutamate receptors","volume":"18","author":"Saugstad","year":"1998","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jbc.2022.102228_bib17","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1152\/jn.1996.76.4.2691","article-title":"Metabotropic glutamate receptors coupled to IP3 production mediate inhibition of IAHP in rat dentate granule neurons","volume":"76","author":"Abdul-Ghani","year":"1996","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.jbc.2022.102228_bib18","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nature22044","article-title":"Antisense oligonucleotide therapy for spinocerebellar ataxia type 2","volume":"544","author":"Scoles","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2022.102228_bib19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A\u00a0simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J.\u00a0Biomol. Screen."},{"key":"10.1016\/j.jbc.2022.102228_bib20","doi-asserted-by":"crossref","first-page":"80ps16","DOI":"10.1126\/scitranslmed.3001862","article-title":"The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics","volume":"3","author":"Huang","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jbc.2022.102228_bib21","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1073\/pnas.1311846111","article-title":"High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells","volume":"111","author":"Mathews Griner","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2022.102228_bib22","doi-asserted-by":"crossref","first-page":"6976","DOI":"10.1038\/s41598-018-25404-w","article-title":"HSP90 inhibitors disrupt a transient HSP90-HSF1 interaction and identify a noncanonical model of HSP90-mediated HSF1 regulation","volume":"8","author":"Kijima","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2022.102228_bib23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0092-8674(00)81588-3","article-title":"Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1","volume":"94","author":"Zou","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2022.102228_bib24","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/ana.26069","article-title":"Staufen1 in human neurodegeneration","volume":"89","author":"Paul","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jbc.2022.102228_bib25","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1001\/jamaneurol.2014.2082","article-title":"Amyotrophic lateral sclerosis risk for spinocerebellar ataxia type 2 ATXN2 CAG repeat alleles: a meta-analysis","volume":"71","author":"Neuenschwander","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jbc.2022.102228_bib26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/hmg\/dds427","article-title":"Changes in Purkinje cell firing and gene expression precede behavioral pathology in a mouse model of SCA2","volume":"22","author":"Hansen","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2022.102228_bib27","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1038\/s41418-020-0553-9","article-title":"Staufen 1 amplifies proapoptotic activation of the unfolded protein response","volume":"27","author":"Gandelman","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jbc.2022.102228_bib28","doi-asserted-by":"crossref","first-page":"134678","DOI":"10.1016\/j.neulet.2019.134678","article-title":"HSP70 and HSP90 in neurodegenerative diseases","volume":"716","author":"Gupta","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jbc.2022.102228_bib29","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.tips.2016.11.009","article-title":"Heat shock proteins and cancer","volume":"38","author":"Wu","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jbc.2022.102228_bib30","doi-asserted-by":"crossref","first-page":"109500","DOI":"10.1016\/j.cellsig.2019.109500","article-title":"Hsp90 inhibitors induce the unfolded protein response in bovine and mice lung cells","volume":"67","author":"Kubra","year":"2020","journal-title":"Cell Signal."},{"key":"10.1016\/j.jbc.2022.102228_bib31","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1182\/blood-2010-04-278853","article-title":"The Hsp90 inhibitor IPI-504 overcomes bortezomib resistance in mantle cell lymphoma in\u00a0vitro and in\u00a0vivo by down-regulation of the prosurvival ER chaperone BiP\/Grp78","volume":"117","author":"Roue","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2022.102228_bib32","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.18632\/oncotarget.6361","article-title":"Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP\/Grp78 and turning on the pro-apoptotic NF-kappaB","volume":"7","author":"Buontempo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2022.102228_bib33","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/14786410902991878","article-title":"Dual effects of ouabain, digoxin and proscillaridin A on the regulation of apoptosis in human fibroblasts","volume":"24","author":"Winnicka","year":"2010","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.jbc.2022.102228_bib34","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/jnen\/nlac032","article-title":"Parallel appearance of polyglutamine and transactivation-responsive DNA-binding protein 43 and their complementary subcellular localization in brains of patients with spinocerebellar ataxia type 2","volume":"81","author":"Koyano","year":"2022","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jbc.2022.102228_bib35","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.neuron.2019.05.048","article-title":"Small-molecule modulation of TDP-43 recruitment to stress granules prevents persistent TDP-43 accumulation in ALS\/FTD","volume":"103","author":"Fang","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.jbc.2022.102228_bib36","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.3390\/cells10123341","article-title":"Cardiac glycosides as autophagy modulators","volume":"10","author":"Skubnik","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jbc.2022.102228_bib37","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.cell.2013.05.037","article-title":"Eukaryotic stress granules are cleared by granulophagy and Cdc48\/VCP function","volume":"153","author":"Buchan","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2022.102228_bib38","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.biopha.2018.03.102","article-title":"Targeted cancer therapy through 17-DMAG as an Hsp90 inhibitor: overview and current state of the art","volume":"102","author":"Mellatyar","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jbc.2022.102228_bib39","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1111\/bph.12609","article-title":"A\u00a0physiologically based pharmacokinetic model of alvespimycin in mice and extrapolation to rats and humans","volume":"171","author":"Hu","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jbc.2022.102228_bib40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00280-004-0939-2","article-title":"In\u00a0vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative","volume":"56","author":"Hollingshead","year":"2005","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jbc.2022.102228_bib41","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/bjc.2014.653","article-title":"A\u00a0first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignancies","volume":"112","author":"Spreafico","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jbc.2022.102228_bib42","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s13311-013-0255-9","article-title":"Chronic treatment with 17-DMAG improves balance and coordination in a new mouse model of Machado-Joseph disease","volume":"11","author":"Silva-Fernandes","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jbc.2022.102228_bib43","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000101849","article-title":"Small molecule inducers of heat-shock response reduce polyQ-mediated huntingtin aggregation. A possible therapeutic strategy","volume":"4","author":"Herbst","year":"2007","journal-title":"Neurodegener Dis."},{"key":"10.1016\/j.jbc.2022.102228_bib44","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/hmg\/ddn419","article-title":"17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse","volume":"18","author":"Tokui","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2022.102228_bib45","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41467-017-00314-z","article-title":"Identification of HSP90 inhibitors as a novel class of senolytics","volume":"8","author":"Fuhrmann-Stroissnigg","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2022.102228_bib46","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1093\/hmg\/dds349","article-title":"ETS1 regulates the expression of ATXN2","volume":"21","author":"Scoles","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2022.102228_bib48","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/bioinformatics\/btl126","article-title":"HTS-Corrector: software for the statistical analysis and correction of experimental high-throughput screening data","volume":"22","author":"Makarenkov","year":"2006","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jbc.2022.102228_bib47","doi-asserted-by":"crossref","first-page":"11473","DOI":"10.1073\/pnas.0604348103","article-title":"Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries","volume":"103","author":"Inglese","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925822006706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925822006706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:53:35Z","timestamp":1777409615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925822006706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0021925822006706"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2022.102228","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A quantitative high-throughput screen identifies compounds that lower expression of the SCA2-and ALS-associated gene ATXN2","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2022.102228","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"102228"}}